High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals

被引:30
作者
Manunta, P
Iacoviello, M
Forleo, C
Messaggio, E
Hamlyn, JM
Lucarelli, K
Guida, P
Romito, R
De Tommasi, E
Bianchi, G
Rizzon, P
Pitzalis, MV
机构
[1] Univ Vita & Salute, Hosp San Raffaele, Div Nephrol Dialysis & Hypertens, I-20132 Milan, Italy
[2] Univ Bari, Inst Cardiol, Bari, Italy
[3] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA
关键词
sodium-pump inhibitors; left ventricular hypertrophy; high blood pressure;
D O I
10.1097/01.hjh.0000177049.38417.67
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Impaired diastolic function and left ventricular hypertrophy can occur early in the natural history of essential hypertension. High circulating levels of endogenous ouabain (EO) have been described in essential hypertension and have also been associated with left ventricular hypertrophy. The aim of this study was to investigate whether these cardiac modifications are related to plasma EO levels in the offspring of hypertensive families. Methods The study involved 41 subjects with (FAM+) and 45 subjects without (FAM-) a family history of hypertension. Arterial blood pressure, left ventricular geometry and function, and plasma EO levels were measured in each subject. Results Plasma EO levels were higher in the FAM+ subjects (221.5 +/- 10.95 versus 179.6 +/- 9.58 pmol/l, P = 0.004), and directly correlated with both systolic (r = 0.417, P < 0.0001) and diastolic blood pressure (r = 0.333, P = 0.002). Plasma EO was inversely related to an index of cardiac diastolic function determined as the ratio between the early and late peak flow velocity (r = -0.286, P = 0.012) and isovolumetric relaxation time (IVRT) (r = 0.32, P = 0.003). The IVRT was also significantly higher in FAM+, correlated with the IVRT (r = 0.32, P = 0.003). The IVRT was also significantly higher in FAM+, whereas the other echocardiographic parameters were similar to FAM-. Conclusions Among the offspring of families with a positive history of hypertension, circulating EO levels and blood pressure are increased. Plasma EO levels are related to alterations of some indexes of diastolic heart function in these individuals. (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:1677 / 1681
页数:5
相关论文
共 25 条
[1]   Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension [J].
Aeschbacher, BC ;
Hutter, D ;
Fuhrer, J ;
Weidmann, P ;
Delacrétaz, E ;
Allemann, Y .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (02) :106-113
[2]   2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[3]   Ouabain, a steroid hormone that signals with slow calcium oscillations [J].
Aizman, O ;
Uhlén, P ;
Lal, M ;
Brismar, H ;
Aperia, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (23) :13420-13424
[4]   Ouabain-induced signaling and vascular smooth muscle cell proliferation [J].
Aydemir-Koksoy, A ;
Abramowitz, J ;
Allen, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) :46605-46611
[5]   PERFORMANCE OF PRIMARY AND DERIVED M-MODE ECHOCARDIOGRAPHIC MEASUREMENTS FOR DETECTION OF LEFT-VENTRICULAR HYPERTROPHY IN NECROPSIED SUBJECTS AND IN PATIENTS WITH SYSTEMIC HYPERTENSION, MITRAL REGURGITATION AND DILATED CARDIOMYOPATHY [J].
DEVEREUX, RB ;
CASALE, PN ;
KLIGFIELD, P ;
EISENBERG, RR ;
MILLER, D ;
CAMPO, E ;
ALONSO, DR .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (15) :1388-1393
[6]   Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238 [J].
Ferrandi, M ;
Molinari, I ;
Barassi, P ;
Minotti, E ;
Bianchi, G ;
Ferrari, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33306-33314
[7]   OUABAIN-LIKE FACTOR IN MILAN HYPERTENSIVE RATS [J].
FERRANDI, M ;
MINOTTI, E ;
SALARDI, S ;
FLORIO, M ;
BIANCHI, G ;
FERRARI, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04) :F739-F748
[8]   Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases [J].
Haas, A ;
Wang, HJ ;
Tian, J ;
Xie, ZJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) :18694-18702
[9]   Endogenous ouabain, sodium balance and blood pressure: A review and a hypothesis [J].
Hamlyn, JM ;
Hamilton, BP ;
Manunta, P .
JOURNAL OF HYPERTENSION, 1996, 14 (02) :151-167
[10]   IDENTIFICATION AND CHARACTERIZATION OF A OUABAIN-LIKE COMPOUND FROM HUMAN PLASMA [J].
HAMLYN, JM ;
BLAUSTEIN, MP ;
BOVA, S ;
DUCHARME, DW ;
HARRIS, DW ;
MANDEL, F ;
MATHEWS, WR ;
LUDENS, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6259-6263